2870
|
20-3912942
|
|
(Primary
Standard Industrial
Classification
Code Number)
|
(I.R.S.
Employer Identification
Number)
|
Large
accelerated filer o
|
Accelerated
filer o
|
|
Non-accelerated
filer o
|
Smaller
reporting company x
|
Title of each class of securities to be registered
|
Amount to be
registered
|
Proposed
maximum
offering
price per
share (5)
|
Proposed
maximum
aggregate offering
price
|
Amount of
registration fee
|
||||||||||
Common
stock underlying convertible notes, par value $0.001 per share
(1)
|
1,000,000
shares
|
$ | 0.14 | $ | 140,000 | $ | 5.50 | |||||||
Common
stock underlying investor warrants, par value $0.001 per share
(2)
|
500,000
shares
|
$ | 0.14 | $ | 70,000 | $ | 2.75 | |||||||
Common
stock underlying placement agent warrants, par value $0.001 per share
(3)
|
80,000
shares
|
0.14 | $ | 11,200 | $ | 0.44 | ||||||||
Common
stock underlying underwriter warrants, par value $0.001 per share
(4)
|
37,980
shares
|
$ | 0.14 | $ | 5,317.20 | $ | 0.21 | |||||||
Total
|
1,617,980
shares
|
$ | 0.14 | $ | 226,517.20 | $ | 8.90 |
Prospectus
Summary
|
3
|
|||
The
Offering
|
3
|
|||
Risk
Factors
|
4
|
|||
Forward
Looking Statements
|
2
|
|||
Business
|
||||
Management's
Discussion and Analysis of Financial Condition or Plan of
Operations
|
13
|
|||
Market
for Registrant's Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities
|
17
|
|||
Dividend
Policy
|
||||
Selling
Security holders
|
18
|
|||
Management
|
||||
Certain
Relationships and Related Transactions
|
||||
Plan
of Distribution
|
23
|
|||
Description
of Capital Stock
|
24
|
|||
Legal
Matters
|
25
|
|||
Experts
|
25
|
|||
Where
You Can Find Additional Information
|
25
|
|||
Consolidated
Financial Statements
|
F-1
|
The
Offering
|
||
Shares
of common stock offered by the selling security holders
|
Up
to 1,617,980 shares of common stock, including (i) 500,000 Investor
Warrant Shares (ii) 80,000 Placement Agent Warrant Shares, (iii) 37,980
Underwriter Warrant Shares and (iv) 1,000,000 Conversion Shares. Assuming
the full conversion of all of the Notes, and the full exercise of the
Investor Warrants and the Placement Agent Warrants, the shares being
registered would represent approximately 11% of our outstanding common
stock. (1)
|
|
Common
stock to be outstanding after the offering
|
Up
to 14,576,554 shares, assuming the conversion of all of the Notes,
and the exercise of all of the Warrants. (1)
|
|
Use
of proceeds
|
China
Agri will not receive any proceeds from the sale of the shares of common
stock offered by the selling security holders to the public. However,
China Agri will receive proceeds from any cash exercise of the Warrants.
Any such proceeds will be used to support the Company's expansion plans
and for working capital.
|
|
OTCBB
Ticker Symbol
|
CHBU
|
·
|
Innovations
or new products by our competitors;
|
|
·
|
Severe
weather or other natural catastrophes in the PRC;
|
|
·
|
Regulatory
developments in the PRC or actions taken by PRC regulatory agencies with
respect to our products, manufacturing process or sales and marketing
activities;
|
|
·
|
Regulatory
developments in the United States with respect to securities of companies
with business activities in the PRC;
|
|
·
|
The
success of our research and development efforts;
|
|
·
|
Any
intellectual property infringement action, or any other litigation,
involving us;
|
|
·
|
Actual
or anticipated fluctuations in our operating results;
|
|
·
|
Our
ability to remain quoted on the OTC Bulletin Board;
|
|
·
|
Sales
of large blocks of our common stock;
|
|
·
|
Sales
of our common stock by our executive officers, directors and significant
stockholders; and
|
|
·
|
The
loss of any of our key personnel.
|
Registration
No.
|
Trademark
|
Product
Name
|
Renewal
Date
|
Expiration
Date
|
||||
No.
(2004) 1485
|
Xinsheng
Luyuan
|
Xinsheng
Luyuan
|
August
2008
|
September
2009
|
||||
No.
(2004) 1542
|
Xinsheng
Lufeng
|
Xinsheng
Lufeng
|
September
2008
|
October
2009
|
||||
No.
(2007) 2968
|
Xinsheng
Huang-jin-gai
|
Xinsheng
Huang-jin-gai
|
December
2008
|
December
2009
|
||||
No.
(2007) 2969
|
Xinsheng
Bai-le
|
Xinsheng
Bai-le
|
December
2008
|
December
2009
|
||||
No.
(2007) 2970
|
Xinsheng
Jia-tian-xia
|
Xinsheng
Jia-tian-xia
|
December
2008
|
December
2009
|
Company Name
|
Location within PRC
|
|
Weifang
Xinde Bio-tech Co., Ltd.
|
Shandong
Province
|
|
Shaanxi
Haide'er Bio-tech Co., Ltd.
|
Shaanxi
Province
|
|
Weifang
Hengsheng Bio-tech Co., Ltd.
|
Shandong
Province
|
|
Zhejiang
Lanhai Bio-engineering Co., Ltd.
|
Zhejiang
Province
|
|
Aiwo
Beijing Agricultural Technology Co., Ltd.
|
Beijing
City
|
|
China
Green Agriculture, Inc.
|
Shaanxi
Province
|
|
Shandong
Dongyan Kefeng Bio-tech Co., Ltd.
|
Shangdong
Province
|
|
Shandong
Tianda Bio-tech Co., Ltd.
|
Shangdong
Province
|
|
Guangxi
Beihai Guofa Bio-tech Co., Ltd.
|
Guangxi
Province
|
Trademark
|
Registration
Number
|
Expiration
|
||
Xinsheng
Shi ji
|
3412688
|
July
2014
|
||
Xinsheng
Luyuan
|
4734942
|
September
2015
|
||
Xinsheng
Lufeng
|
4734940
|
September
2015
|
||
Xinsheng
Huang-jin-gai
|
6213163
|
August
2022
|
||
Xinsheng
Bai-le
|
6212924
|
August
2022
|
||
Xinsheng
Jia-tian-xia
|
6213164
|
August
2022
|
||
New
Agriculture - Generator
|
6952690
|
September
2023
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
September 30,
2008
|
September 30,
2007
|
September 30,
2008
|
September 30,
2007
|
|||||||||||||
Sales
|
$ | 612,301 | $ | 781,103 | $ | 2,134,491 | $ | 2,190,006 | ||||||||
Less:
Cost of Goods Sold
|
154,222 | 238,254 | 612,799 | 695,147 | ||||||||||||
Gross
Profit
|
$ | 458,079 | $ | 542,849 | $ | 1,521,692 | $ | 1,494,859 | ||||||||
Gross
Profit Margin
|
74.81 | % | 69.50 | % | 71.29 | % | 68.26 | % | ||||||||
Net
Income
|
$ | 389,560 | $ | 286,461 | $ | 1,182,771 | $ | 855,638 |
Revenue
Recognition and Deferred Income
|
High Sales
Price
|
Low Sales
Price
|
|||||||
Year
Ended December 31, 2009:
|
||||||||
1st
Quarter (through February 11, 2009)
|
$ | 0.23 | $ | 0.10 | ||||
Year
Ended December 31, 2008:
|
||||||||
4th
Quarter
|
$ | 0.55 | $ | 0.10 | ||||
3rd
Quarter
|
$ | 0.51 | $ | 0.25 | ||||
2nd
Quarter
|
$ | 1.50 | $ | 0.42 | ||||
1st
Quarter
|
$ | 1.00 | $ | 0.40 | ||||
Year
Ended December 31, 2007:
|
||||||||
4th
Quarter (from October 17, 2007 to December 31, 2007)
|
$ | 2.00 | $ | 0.62 |
Name
|
Total Shares
Issuable Upon
Conversion of
Notes
Plus shares
Issuable Upon
Exercise of
Warrants (1)
|
Total
Percentage
of Common
Stock,
Assuming
Full
Exercise (1)
|
Shares of
Common Stock
Included in
Prospectus
(2)
|
Beneficial
Ownership
Before the
Offering (3)
|
Percentage of
Common Stock
Owned Before
Offering (3)
|
Beneficial
Ownership
After the
Offering
(4)
|
Percentage
of Common
Stock Owned
After
Offering
(4)
|
|||||||||||||||||||||
JAG
Multi Investment (5)
|
750,000 |
6
|
%
|
750,000 | 750,000 | 6 | % | — | — | |||||||||||||||||||
Keith
Guenther (6)
|
750,000 |
6
|
%
|
750,000 | 750,000 | 6 | % | — | — | |||||||||||||||||||
Legend
Merchant Group, Inc. (7)
|
80,000 | * | 80,000 | 80,000 | * | — | — | |||||||||||||||||||||
Spencer
Edwards, Inc. (8)
|
37,980 | * | 37,980 | 37,980 | * | — | — | |||||||||||||||||||||
TOTALS
|
1,617,980 | 1,617,980 | 1,617,980 |
NAME
|
POSITION
|
AGE
|
||
Liping
Deng
|
Director,
Chief Executive Officer and President
|
36
|
||
Limin
Deng
|
Chairman
of Board of Directors
|
45
|
||
Xiaolong
Zhou
|
Chief
Financial Officer
|
56
|
||
Jianhua
Wang
|
Secretary
|
54
|
||
Michael
Segal
|
Director
|
66
|
NAME
|
POSITION
|
AGE
|
||
Liping
Deng
|
Chairman
of Board of Directors
|
36
|
||
Limin
Deng
|
Vice-Chairman
of Board of Directors
|
45
|
||
Zhengfeng
Guo
|
Director
|
38
|
NAME
|
POSITION
|
AGE
|
||
Liping
Deng
|
Director,
and President
|
35
|
||
Limin
Deng
|
Chairman
of Board of Directors
|
44
|
||
Yuqin
Mao
|
Director
and Chief Financial Officer
|
58
|
||
Jianhua
Wang
|
Director
and Administrative Department Head
|
53
|
||
Xiucheng
Wang
|
Director
and Vice President
|
57
|
||
Ruixin
Zhang
|
Director
and Vice President
|
48
|
·
|
each
person known by us to be the beneficial owner of more than 5% of our
outstanding shares of common stock;
|
|
·
|
each
of our officers and directors; and
|
|
·
|
all
our officers and directors as a
group.
|
Name of Beneficial Owner
|
Amount and
Nature of
Beneficial
Ownership (1)
|
Percent of
Class
|
||||||
Michael
Segal
11
East 86th Street
New
York, New York 10028
|
63,074 | 0.5 | % | |||||
Liping
Deng
|
1,851,148 | 14.3 | ||||||
Liming
Deng
|
— | — | ||||||
Xialong
Zhou
|
— | — | ||||||
All
Directors and Executive Officers as a group (4 persons)
|
1,914,222 | 14.8 | % | |||||
Trustees
for Xinsheng Shareholders (2)
|
9,099,749 | 70.2 |
Name and Principal
Position
(a)
|
Year
(b)
|
Salary
($)
(c)
|
Bonus
($)
(d)
|
Stock
Awards
($)
(e)
|
Option
Awards
($)
(f)
|
Non-Equity
Incentive
Plan
Compensation
($)
(g)
|
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
($)
(h)
|
All Other
Compensation
($)
(i)
|
Total
($)
(j)
|
|||||||||||||||||||||||||
Liping
Deng
Chief
Executive Officer (1)
|
2007
|
5,260 | — | — | — | — | — | — | 5,260 | |||||||||||||||||||||||||
2006
|
3,994 | — | — | — | — | — | — | 3,994 |
DIRECTOR COMPENSATION
|
||||||||||||||||||||||||||||
Name
(a)
|
Fees
Earned or
Paid in
Cash
($)
(b)
|
Stock
Awards
($)
(c)
|
Option
Awards
($)
(d)
|
Non-Equity
Incentive
Plan
Compensation
($)
(e)
|
Non-Qualified
Deferred
Compensation
Earnings
($)
(f)
|
All
Other
Compensation
($)
(g)
|
Total
($)
(j)
|
|||||||||||||||||||||
Limin
Deng
|
7,140 | — | — | — | — | — | 7,140 |
|
•
|
ordinary
brokerage transactions and transactions in which the broker-dealer
solicits purchasers;
|
|
•
|
block
trades in which the broker-dealer will attempt to sell the shares as agent
but may position and resell a portion of the block as principal to
facilitate the transaction;
|
|
•
|
purchases
by a broker-dealer as principal and resale by the broker-dealer for its
account;
|
|
•
|
an
exchange distribution in accordance with the rules of the applicable
exchange;
|
|
•
|
privately
negotiated transactions;
|
|
•
|
settlement
of short sales entered into after the effective date of the registration
statement of which this prospectus is a
part;
|
|
•
|
broker-dealers
may agree with the selling security holders to sell a specified number of
such shares at a stipulated price per
share;
|
|
•
|
through
the writing or settlement of options or other hedging transactions,
whether through an options exchange or
otherwise;
|
|
•
|
a
combination of any such methods of sale;
or
|
|
•
|
any
other method permitted pursuant to applicable
law.
|
Amount to
|
||||
Be Paid
|
||||
SEC
registration fee
|
$
|
8.90
|
||
Legal
fees and expenses
|
$
|
25,000
|
||
Accounting
fees and expenses
|
$
|
5,000
|
||
Miscellaneous
|
$
|
2000
|
||
Total
|
$
|
32,008.90
|
3.1.1
|
Articles
of incorporation (1)
|
|
3.2
|
By-Laws
(1)
|
|
3.3
|
Articles
of Incorporation, as amended (1)
|
|
4.1
|
Form
of 3% Convertible Note (2)
|
|
4.2
|
Form
of Series C Warrant (2)
|
|
4.3
|
Form
of Series D Warrant (2)
|
|
4.4
|
Form
of 2007 Underwriter Warrant *
|
|
4.5
|
Form
of 2009 Placement Agent Warrant *
|
|
5.1
|
Legal
Opinion (To be filed by amendment)
|
|
9.1
|
Stock
Purchase Agreement between Company and Xinsheng Shareholders dated April
22, 2006. (1)
|
|
9.2
|
Management
Agreement between Xinsheng and WOFE dated April 18,2006.
(1)
|
|
9.3
|
Voting
Trust and Escrow Agreement with Xinsheng Shareholders and their trustee
dated April 22 2006. (1)
|
|
10.1
|
Form
of Subscription Agreement (2)
|
|
10.2
|
Form
of Registration Rights Agreement (2)
|
|
21.1
|
Subsidiaries
of the small business issuer (1)
|
|
23.1
|
Consent
of Michael Studer CPA PC *
|
|
23.2
|
Legal
Opinion (see Exhibit 5.1)
|
CHINA
AGRI-BUSINESS, INC.
|
||
By: | /s/ Liping Deng | |
|
Name: Liping Deng
Title: Chief Executive Officer and President (Principal Executive
Officer)
|
By:
|
/s/ Xialong Zhou | |
|
Name: Xialong Zhou
Title: Chief Financial Officer, (Principal Accounting and Financial
Officer)
|
By:
|
/s/ Liping Deng
|
February 13, 2009
|
|
Name:
Liping Deng
Title:
Chief Executive Officer and President (Principal Executive
Officer)
|
|
By:
|
/s/ Xialong Zhou
|
February 13, 2009
|
|
Name:
Xialong Zhou
Title:
Chief Financial Officer (Principal Accounting and Financial
Officer)
|
|
By:
|
/s/ Michael Segal
|
February 13, 2009
|
|
Name:
Michael Segal
Title:
Director
|
|
By:
|
/s/ Limin Deng
|
February 13, 2009
|
|
Name:
Limin Deng
Title:
Director
|
|
September 30,
|
December 31,
|
|||||||
2008
|
2007
|
|||||||
(Unaudited)
|
(Audited)
|
|||||||
Assets
|
||||||||
Current
Assets
|
||||||||
Cash
and cash equivalents
|
$ | 8,169,272 | $ | 5,984,448 | ||||
Accounts
receivable, net of allowance for doubtful accounts of $7,344
and $23,991, respectively
|
43,730 | 65,118 | ||||||
Inventory
|
69,881 | 60,582 | ||||||
Other
receivables
|
7,364 | 6,855 | ||||||
Prepaid
expenses
|
4,228 | 5,735 | ||||||
Total
Current Assets
|
8,294,475 | 6,122,738 | ||||||
Property,
plant and equipment, net
|
244,155 | 276,000 | ||||||
Investment
in Tienwe Technology
|
883,680 | 822,540 | ||||||
Deferred
financing costs, net of accumulated amortization of $475 and $0,
respectively
|
149,965 | - | ||||||
Intangible
assets, net
|
64,728 | 73,554 | ||||||
Total
Assets
|
$ | 9,637,003 | $ | 7,294,832 | ||||
Liabilities
and Stockholders' Equity
|
||||||||
Current
Liabilities
|
||||||||
Accounts
payable and accrued liabilities
|
$ | 243,117 | $ | 166,200 | ||||
Customer
deposits and deferred income
|
— | — | ||||||
Total
Current Liabilities
|
243,117 | 166,200 | ||||||
Long
Term Liabilities
|
||||||||
Convertible
notes, net
|
300,913 | — | ||||||
Total
Liabilities
|
300,913 | — | ||||||
Stockholders'
Equity
|
||||||||
Undesignated
preferred stock, par value $.001 per share;
authorized 4,900,000 shares; none issued
|
— | — | ||||||
Common
stock, par value $.001 per share; authorized 100,000,000
shares, issued and outstanding 12,958,574 and 12,958,574
shares, respectively
|
12,959 | 12,959 | ||||||
Additional
paid-in capital
|
4,369,786 | 4,150,636 | ||||||
Retained
earnings
|
3,491,644 | 2,308,873 | ||||||
Accumulated
other comprehensive income
|
1,218,584 | 656,164 | ||||||
Total
stockholders' equity
|
9,092,973 | 7,128,632 | ||||||
Total
Liabilities and Stockholders' Equity
|
$ | 9,637,003 | $ | 7,294,832 |
Three Months Ended
|
Nine Months Ended
|
||||||||||||
September 30,
|
September 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
Sales
of products
|
$
|
612,301
|
$
|
781,103
|
$
|
2,134,491
|
$
|
2,190,006
|
|||||
Cost
of goods sold
|
154,222
|
238,254
|
612,799
|
695,147
|
|||||||||
Gross
profit
|
458,079
|
542,849
|
1,521,692
|
1,494,859
|
|||||||||
Selling,
general and administrative expenses
|
78,118
|
261,232
|
360,037
|
650,140
|
|||||||||
Income
from operations
|
379,961
|
281,617
|
1,161,655
|
844,719
|
|||||||||
Interest
and other income
|
10,217
|
4,844
|
21,734
|
10,919
|
|||||||||
Interest
expense
|
(618
|
)
|
—
|
(618
|
)
|
—
|
|||||||
Income
before income taxes
|
389,560
|
286,461
|
1,182,771
|
855,638
|
|||||||||
Income
taxes
|
—
|
—
|
—
|
—
|
|||||||||
Net
income
|
$
|
389,560
|
$
|
286,461
|
$
|
1,182,771
|
$
|
855,638
|
|||||
Earnings
per common share:
|
|||||||||||||
Basic
|
$
|
0.03
|
$
|
0.02
|
$
|
0.09
|
$
|
0.07
|
|||||
Diluted
|
$
|
0.03
|
$
|
0.02
|
$
|
0.09
|
$
|
0.07
|
|||||
Weighted
average number of common shares used to compute earnings per
common share:
|
|||||||||||||
Basic
|
12,958,574
|
12,278,774
|
12,958,574
|
12,278,774
|
|||||||||
Diluted
|
12,980,313
|
12,578,774
|
12,965,900
|
12,578,774
|
Accumulated
|
|||||||||||||||||||
Additional
|
Other
|
||||||||||||||||||
Common Stock
|
Paid-in
|
Retained
|
Comprehensive
|
||||||||||||||||
Shares
|
Amount
|
Capital
|
Earnings
|
Income
|
Total
|
||||||||||||||
Balance,
December 31, 2006
|
12,278,774
|
$
|
12,279
|
$
|
3,629,709
|
1,449,991
|
$
|
232,272
|
$
|
5,324,251
|
|||||||||
Sales
of Units in public offering
|
379,800
|
380
|
379,420
|
—
|
—
|
379,800
|
|||||||||||||
Costs
relating to the public offering
|
—
|
—
|
(158,193
|
)
|
—
|
—
|
(158,193
|
)
|
|||||||||||
Conversion
of Series A preferred stock
|
300,000
|
300
|
99,700
|
—
|
—
|
100,000
|
|||||||||||||
Deemed
dividend relating to beneficial conversion feature of Series A preferred
stock
|
—
|
—
|
200,000
|
(200,000
|
)
|
—
|
—
|
||||||||||||
Net
income for the year ended December 31, 2007
|
—
|
—
|
—
|
1,058,882
|
—
|
1,058,882
|
|||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
423,892
|
423,892
|
|||||||||||||
Balance,
December 31, 2007
|
12,958,574
|
12,959
|
4,150,636
|
2,308,873
|
656,164
|
7,128,632
|
|||||||||||||
Unaudited:
|
|||||||||||||||||||
Relative
fair value of warrants and beneficial conversion feature
|
—
|
—
|
219,150
|
—
|
—
|
219,150
|
|||||||||||||
Net
income for the nine months ended September 30, 2008
|
—
|
—
|
—
|
1,182,771
|
—
|
1,182,771
|
|||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
562,420
|
562,420
|
|||||||||||||
Balance,
September 30, 2008
|
12,958,574
|
$
|
12,959
|
$
|
4,369,786
|
3,491,644
|
$
|
1,218,584
|
$
|
9,092,973
|
Nine Months Ended
|
|||||||
September 30,
|
|||||||
2008
|
2007
|
||||||
(Unaudited)
|
(Unaudited)
|
||||||
Operating
activities
|
|||||||
Net
income
|
$
|
1,182,771
|
$
|
855,638
|
|||
Adjustments
to reconcile net income to net cash provided by (used in)
operating activities:
|
|||||||
Bad
debt expense
|
13,318
|
—
|
|||||
Depreciation
of property, plant and equipment
|
37,029
|
32,503
|
|||||
Amortization
of intangible assets and deferred financing costs
|
15,032
|
1,764
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
8,070
|
(34,103
|
)
|
||||
Other
receivables
|
(509
|
)
|
4,560
|
||||
Inventory
|
(9,299
|
)
|
7,194
|
||||
Prepaid
expenses
|
1,507
|
(31,760
|
)
|
||||
Accounts
payable and accrued liabilities
|
76,917
|
162,786
|
|||||
Net
cash provided by operating activities
|
1,324,836
|
998,582
|
|||||
Investing
activities
|
|||||||
Loans
receivable collections
|
—
|
296,629
|
|||||
Property,
plant and equipment additions
|
(4,742
|
)
|
(27,685
|
)
|
|||
Net
cash provided by (used in) investing activities
|
(4,742
|
)
|
268,944
|
||||
Financing
actitivies
|
|||||||
Proceeds
from convertible notes
|
483,680
|
—
|
|||||
Financing
costs
|
(114,200
|
)
|
(51,919
|
)
|
|||
Net
cash provided by (used in) financing actitives
|
369,480
|
(51,919
|
)
|
||||
Effect
of exchange rate changes on cash and cash equivalents
|
495,250
|
214,182
|
|||||
Increase
in cash and cash equivalents
|
2,184,824
|
1,429,789
|
|||||
Cash
and cash equivalents, beginning of period
|
5,984,448
|
3,785,535
|
|||||
Cash
and cash equivalents, end of period
|
$
|
8,169,272
|
$
|
5,215,324
|
|||
Supplemental
Disclosures of Cash Flow Informtion:
|
|||||||
Non
Cash Financing Activities:
|
|||||||
Relative
fair value of warrants and beneficial conversion feature
|
$
|
219,150
|
$
|
—
|
Inventory consists of:
|
September 30,
|
December 31,
|
|||||
2008
|
2007
|
||||||
(Unaudited)
|
|||||||
Raw materials
|
$
|
58,628
|
$
|
52,953
|
|||
Finished
goods
|
7,784
|
5,342
|
|||||
Other
|
3,469
|
2,287
|
|||||
Total
inventory
|
$
|
69,881
|
$
|
60,582
|
September 30,
|
December 31,
|
||||||
2008
|
2007
|
||||||
(Unaudited)
|
|||||||
Building
|
$
|
19,794
|
$
|
18,425
|
|||
Transportation
equipment
|
227,560
|
271,081
|
|||||
Manufacturing
equipment and machinery
|
132,266
|
123,798
|
|||||
Office
and computer equipment
|
17,535
|
16,448
|
|||||
397,155
|
429,752
|
||||||
Less
accumulated depreciation
|
153,000
|
153,752
|
|||||
Property,
plant and equipment, net
|
$
|
244,155
|
$
|
276,000
|
September 30,
2008
|
December 31,
2007
|
||||||
(Unaudited)
|
|||||||
Placement Agent commissions
|
$
|
40,000
|
$
|
—
|
|||
Placement
Agent expense allowance
|
25,000
|
—
|
|||||
Fair
value of Placement Agent warrants
|
19,920
|
—
|
|||||
Legal
and other fees
|
65,520
|
—
|
|||||
Total
|
150,440
|
—
|
|||||
Less:
accumulated amortization
|
(475
|
)
|
—
|
||||
Balance
at September 30, 2008
|
$
|
149,965
|
$
|
—
|
September 30,
|
December 31,
|
||||||
2008
|
2007
|
||||||
(Unaudited)
|
|||||||
Product
rights
|
$
|
90,577
|
$
|
84,310
|
|||
Patent
|
14,728
|
13,709
|
|||||
Trademark
|
2,200
|
1,555
|
|||||
Total
|
107,505
|
99,574
|
|||||
Less
accumulated amortization
|
42,777
|
26,020
|
|||||
Intangible
assets, net
|
$
|
64,728
|
$
|
73,554
|
September 30,
|
December 31,
|
||||||
2008
|
2007
|
||||||
(Unaudited)
|
|||||||
Convertible
notes - face amount
|
$
|
500,000
|
$
|
—
|
|||
Less:
|
|||||||
Debt
discount attributable to the relative fair value of
warrants
|
(149,615
|
)
|
—
|
||||
Debt
discount attributable to the intrinsic value of the beneficial conversion
feature
|
(49,615
|
)
|
—
|
||||
Less
accumulated amortization of debt discounts
|
143
|
—
|
|||||
Convertible
notes payable, net
|
$
|
300,913
|
$
|
—
|
Nine Months
Ended
September 30,
2008
|
Year Ended
December 31,
2007
|
||||||
(Unaudited)
|
|||||||
Outstanding
at beginning of period
|
807,580
|
10,000
|
|||||
Warrants
issued
|
1,080,000
|
797,580
|
|||||
Warrants
exercised
|
—
|
—
|
|||||
Warrants
expired
|
—
|
—
|
|||||
Outstanding
at end of period
|
1,887,580
|
807,580
|
|||||
Exercisable
at end of period
|
1,887,580
|
807,580
|
Date Issued
|
Expiration Date
|
Number of
Warrants
|
Weighted Average
Exercise Price
|
|||||||
May
31, 2006
|
May
31, 2009
|
10,000
|
$
|
1.50
|
||||||
October
11, 2007
|
October
10, 2010
|
379,800
|
1.50
|
|||||||
October
11, 2007
|
October
10, 2010
|
379,800
|
2.00
|
|||||||
October
11, 2007
|
October
10, 2012
|
37,980
|
1.00
|
|||||||
September
29, 2008
|
September
29, 2011
|
80,000
|
1.00
|
|||||||
September
29, 2008(1)
|
September
29, 2011
|
500,000
|
1.50
|
|||||||
September
29, 2008(2)
|
—
|
500,000
|
2.00
|
|||||||
Total
(Unaudited)
|
1,887,580
|
$
|
1.70
|
(1)
|
Represents
series C warrants.
|
(2)
|
Represents
series D warrants issuable on a one to one basis upon exercise of the
series C warrants. The series D warrants will have a term of three
years.
|
Three Months Ended
|
Nine Months Ended
|
||||||||||||
September 30,
|
September 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
Expected
tax at 35%
|
$
|
136,346
|
$
|
100,261
|
$
|
413,970
|
$
|
299,473
|
|||||
Tax
effect of unutilized losses of China Agri and Meixin
|
(1,336
|
)
|
—
|
15,158
|
—
|
||||||||
Effect
of PRC income tax exemption granted to Xinsheng
|
(96,465
|
)
|
(94,531
|
)
|
(306,549
|
)
|
(282,360
|
)
|
|||||
Permanent
difference relating to Xinsheng's earnings to be permanently
invested in operations outside the United States
|
(38,545
|
)
|
(5,730
|
)
|
(122,579
|
)
|
(17,113
|
)
|
|||||
Actual
provision for income taxes
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
Year ending September
30,
|
Minimum
Rent
|
|||
(Unaudited)
|
||||
2009
|
$
|
59,633
|
||
2010
|
59,633
|
|||
2011
|
14,908
|
|||
Total
|
$
|
134,174
|
Michael
T. Studer, CPA,
P.C.
|
Freeport,
New York
|
March
20, 2008
|
December 31,
|
December 31,
|
||||||
2007
|
2006
|
||||||
Assets
|
|||||||
Current
Assets
|
|||||||
Cash
and cash equivalents
|
$
|
5,984,448
|
$
|
3,785,535
|
|||
Accounts
receivable, net of allowance for doubtful accounts of $23,991 and
$2,665, respectively
|
65,118
|
103,844
|
|||||
Inventory
|
60,582
|
92,253
|
|||||
Other
receivables
|
6,855
|
18,476
|
|||||
Loans
receivable
|
-
|
301,447
|
|||||
Prepaid
expenses
|
5,735
|
22,137
|
|||||
Total
Current Assets
|
6,122,738
|
4,323,692
|
|||||
Property,
plant and equipment, net
|
276,000
|
296,344
|
|||||
Investment
in Tienwe Technology
|
822,540
|
769,477
|
|||||
Intangible
assets, net
|
73,554
|
86,014
|
|||||
Total
Assets
|
$
|
7,294,832
|
$
|
5,475,527
|
|||
Liabilities
and Stockholders' Equity
|
|||||||
Current
Liabilities
|
|||||||
Accounts
payable and accrued liabilities
|
$
|
166,200
|
$
|
51,276
|
|||
Total
Current Liabilities
|
166,200
|
51,276
|
|||||
Redeemable
Series A preferred stock, par value $.001 per share;
authorized
100,000
shares; issued and outstanding 0 and 10,000 shares,
respectively
|
-
|
100,000
|
|||||
Stockholders'
Equity
|
|||||||
Undesignated
preferred stock, par value $.001 per share; authorized 4,900,000 shares;
none issued
|
-
|
-
|
|||||
Common
stock par value $.001 per share; authorized 100,000,000 shares; issued and
outstanding 12,958,574 and 12,278,774 shares, respectively
|
12,959
|
12,279
|
|||||
Additional
paid-in capital
|
4,150,636
|
3,629,709
|
|||||
Retained
earnings
|
2,308,873
|
1,449,991
|
|||||
Accumulated
other comprehensive income
|
656,164
|
232,272
|
|||||
Total
stockholders' equity
|
7,128,632
|
5,324,251
|
|||||
Total
Liabilities and Stockholders' Equity
|
$
|
7,294,832
|
$
|
5,475,527
|
Year Ended
|
|||||||
December 31
|
|||||||
2007
|
2006
|
||||||
Sales
of products
|
$
|
3,037,414
|
$
|
2,154,894
|
|||
Cost
of goods sold
|
964,961
|
655,530
|
|||||
Gross
profit
|
2,072,453
|
1,499,364
|
|||||
Selling,
general and administrative expenses
|
1,029,230
|
592,794
|
|||||
Income
from operations
|
1,043,223
|
906,570
|
|||||
Interest
income
|
15,659
|
6,283
|
|||||
Income
before income taxes
|
1,058,882
|
912,853
|
|||||
Income
taxes
|
-
|
-
|
|||||
Net
income
|
1,058,882
|
912,853
|
|||||
Deemed
dividend relating to beneficial conversion feature of Series A preferred
stock
|
(200,000
|
)
|
-
|
||||
Net
income attributable to common stockholders
|
$
|
858,882
|
$
|
912,853
|
|||
Earnings
per common share:
|
|||||||
Basic
|
$
|
0.07
|
$
|
0.08
|
|||
Diluted
|
$
|
0.07
|
$
|
0.08
|
|||
Weighted
average number of common shares used to compute earnings per common
share:
|
|||||||
Basic
|
12,431,496
|
11,874,954
|
|||||
Diluted
|
12,664,099
|
11,874,954
|
Accumulated
|
|||||||||||||||||||
Additional
|
Retained
|
Other
|
|||||||||||||||||
Common Stock
|
Paid-in
|
Earnings
|
Comprehensive
|
||||||||||||||||
Shares
|
Amount
|
Capital
|
(Deficit)
|
Income
|
Total
|
||||||||||||||
Balance,
December 31, 2005
|
10,950,897
|
10,951
|
3,631,037
|
537,138
|
201,656
|
4,380,782
|
|||||||||||||
Reverse
acquisition of Xinsheng effective April 22,
2006
|
1,327,877
|
1,328
|
(1,328
|
)
|
-
|
-
|
-
|
||||||||||||
Net
income for the year ended
|
|||||||||||||||||||
December
31, 2006
|
-
|
-
|
-
|
912,853
|
-
|
912,853
|
|||||||||||||
Foreign
currency translation adjustment
|
-
|
-
|
-
|
-
|
30,616
|
30,616
|
|||||||||||||
Balance,
December 31, 2006
|
12,278,774
|
12,279
|
3,629,709
|
1,449,991
|
232,272
|
5,324,251
|
|||||||||||||
Sales
of Units in public offering
|
379,800
|
380
|
379,420
|
-
|
-
|
379,800
|
|||||||||||||
Costs
relating to the public offering
|
-
|
-
|
(158,193
|
)
|
-
|
-
|
(158,193
|
)
|
|||||||||||
Conversion
of Series A preferred stock
|
300,000
|
300
|
99,700
|
-
|
-
|
100,000
|
|||||||||||||
Deemed
dividend relating to beneficial conversion feature
|
|||||||||||||||||||
of
Series A preferred stock
|
-
|
-
|
200,000
|
(200,000
|
)
|
-
|
-
|
||||||||||||
Net
income for the year ended December 31, 2007
|
-
|
-
|
-
|
1,058,882
|
-
|
1,058,882
|
|||||||||||||
Foreign
currency translation adjustment
|
-
|
-
|
-
|
-
|
423,892
|
423,892
|
|||||||||||||
Balance,
December 31, 2007
|
12,958,574
|
$
|
12,959
|
$
|
4,150,636
|
$
|
2,308,873
|
$
|
656,164
|
$
|
7,128,632
|
Year Ended
|
|||||||
December 31
|
|||||||
2007
|
2006
|
||||||
Operating activities
|
|
||||||
Net
income
|
$
|
1,058,882
|
$
|
912,853
|
|||
Adjustments
to reconcile net income to net cash provided by (used in)
operating activities:
|
|||||||
Depreciation
of property, plant and equipment
|
44,157
|
38,225
|
|||||
Amortization
of intangible assets
|
17,636
|
1,730
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable, net
|
38,726
|
403,572
|
|||||
Other
receivables
|
11,621
|
(18,476
|
)
|
||||
Inventory
|
31,671
|
(36,764
|
)
|
||||
Prepaid
expenses
|
16,402
|
267,229
|
|||||
Accounts
payable and accrued liabilities
|
114,924
|
19,514
|
|||||
Net
cash provided by operating activities
|
1,334,019
|
1,587,883
|
|||||
Investing
activities
|
|||||||
Loans
receivable collections
|
301,447
|
1,082,863
|
|||||
Property,
plant and equipment additions
|
(32,902
|
)
|
(118,212
|
)
|
|||
Property,
plant and equipment disposals
|
-
|
2,611
|
|||||
Intangible
assets additions
|
-
|
(78,874
|
)
|
||||
Net
cash provided by (used in) investing activities
|
268,545
|
888,388
|
|||||
Financing
activities
|
|||||||
Proceeds
from sale of Units in public offering
|
379,800
|
-
|
|||||
Costs
relating to public offering
|
(158,193
|
)
|
-
|
||||
Proceeds
from sale of Series A preferred stock
|
-
|
100,000
|
|||||
Net
cash provided by (used in) financing activities
|
221,607
|
100,000
|
|||||
Effect
of exchange rate changes on cash and cash equivalents
|
374,742
|
(7,485
|
)
|
||||
Increase
in cash and cash equivalents
|
2,198,913
|
2,568,786
|
|||||
Cash
and cash equivalents, beginning of period
|
3,785,535
|
1,216,749
|
|||||
Cash
and cash equivalents, end of period
|
$
|
5,984,448
|
$
|
3,785,535
|
Property, plant and equipment is
stated at cost less accumulated depreciation. Depreciation is calculated
on a straight-line basis over the estimated useful lives of the respective
assets.
|
(j)
Revenue Recognition
|
2007
|
2006
|
||||||
Weighted
average number of common shares
outstanding
(used to compute basic EPS)
|
12,431,496
|
11,874,954
|
|||||
Assumed
conversion of redeemable
Series
A preferred stock - See Note 9
|
232,603
|
-
|
|||||
Weighted
average number of common shares
and
dilutive common stock equivalents outstanding
(used
to compute diluted EPS)
|
12,664,099
|
11,874,954
|
Inventory consists of:
|
December 31,
|
December 31,
|
|||||
2007
|
2006
|
||||||
Raw
materials
|
$
|
52,953
|
$
|
36,718
|
|||
Work
in progress
|
-
|
3,650
|
|||||
Finished
goods
|
5,342
|
48,573
|
|||||
Other
|
2,287
|
3,312
|
|||||
Total
inventory
|
$
|
60,582
|
$
|
92,253
|
December
31,
|
December
31,
|
||||||
Loans
receivable consist of:
|
2007
|
2006
|
|||||
|
|||||||
Net
Bar, non-interest bearing, due March 31, 2007
|
$
|
-
|
$
|
301,447
|
|||
Total
|
$
|
-
|
$
|
301,447
|
December 31,
|
December 31,
|
||||||
2007
|
2006
|
||||||
|
|
||||||
Building
|
$
|
18,425
|
$
|
17,237
|
|||
Transportation
equipment
|
271,081
|
244,480
|
|||||
Manufacturing
equipment and machinery
|
123,798
|
118,759
|
|||||
Office
and computer equipment
|
16,448
|
16,322
|
|||||
Total
|
429,752
|
396,798
|
|||||
Less
accumulated depreciation
|
(153,752
|
)
|
(100,506
|
)
|
|||
Construction
in progress
|
-
|
52
|
|||||
Property,
plant and equipment, net
|
$
|
276,000
|
$
|
296,344
|
December 31,
|
December 31,
|
||||||
2007
|
2006
|
||||||
|
|||||||
Product
rights
|
$
|
84,310
|
$
|
78,874
|
|||
Patent
|
13,709
|
12,825
|
|||||
Trademark
|
1,555
|
1,212
|
|||||
Total
|
99,574
|
92,911
|
|||||
Less
accumulated amortization
|
26,020
|
6,897
|
|||||
Intangible
assets, net
|
$
|
73,554
|
$
|
86,014
|
Year Ended December 31,
|
|||||||
2007
|
2006
|
||||||
Outstanding
at beginning of period
|
10,000
|
-
|
|||||
Warrants
issued
|
797,580
|
10,000
|
|||||
Warrants
exercised
|
-
|
-
|
|||||
Warrants
expired
|
-
|
-
|
|||||
Outstanding
at end of period
|
807,580
|
10,000
|
|||||
Exercisable
at end of period
|
807,580
|
10,000
|
Date Issued
|
Expiration Date
|
Number of
Warrants
|
Weighted
Average
Exercise Price
|
|||||||
May
31, 2006
|
May
31, 2009
|
10,000
|
$
|
1.50
|
||||||
October
11, 2007
|
October
10, 2010
|
379,800
|
1.50
|
|||||||
October
11, 2007
|
October
10, 2010
|
379,800
|
2.00
|
|||||||
October
11, 2007
|
October
10, 2010
|
37,980
|
1.00
|
|||||||
Total
|
807,580
|
$
|
1.71
|
Year Ended December 31,
|
|||||||
2007
|
2006
|
||||||
Expected
tax at 35%
|
$
|
383,724
|
$
|
319,499
|
|||
Tax
effect of unutilized losses of China Agri and Meixin
|
135,664
|
-
|
|||||
Effect
of PRC income tax exemption granted to Xinsheng
|
(349,431
|
)
|
(301,241
|
)
|
|||
Permanent
difference relating to Xinsheng's earnings
to
be permanently invested in operations outside the United
States
|
(169,957
|
)
|
(18,258
|
)
|
|||
Actual
provision for income taxes
|
$
|
-
|
$
|
-
|
Year ending December 31,
|
|
|||
|
||||
2008
|
$
|
17,367
|
||
2009
|
5,140
|
|||
2010
|
1,285
|
|||
Total
|
$
|
23,792
|